HKD 0.46
(-5.21%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 81.06 Million HKD | -16.74% |
2022 | 97.36 Million HKD | 16.4% |
2021 | 83.65 Million HKD | 274.86% |
2020 | 22.31 Million HKD | -78.61% |
2019 | 104.31 Million HKD | -12.86% |
2018 | 119.71 Million HKD | -2.8% |
2017 | 123.16 Million HKD | 121.08% |
2016 | 55.7 Million HKD | -33.57% |
2015 | 83.86 Million HKD | 3.27% |
2014 | 81.2 Million HKD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 42.91 Million HKD | 0.0% |
2023 Q1 | 18.82 Million HKD | -67.16% |
2023 Q2 | 37.65 Million HKD | 100.0% |
2023 Q3 | 21.7 Million HKD | -42.37% |
2023 Q4 | 43.4 Million HKD | 100.0% |
2023 FY | 81.06 Million HKD | -16.74% |
2022 Q1 | 17.39 Million HKD | -52.28% |
2022 FY | 97.36 Million HKD | 16.4% |
2022 Q4 | 57.33 Million HKD | 100.0% |
2022 Q3 | 28.66 Million HKD | -17.58% |
2022 Q2 | 34.78 Million HKD | 100.0% |
2021 FY | 83.65 Million HKD | 274.86% |
2021 Q1 | 22.59 Million HKD | 339.6% |
2021 Q4 | 36.43 Million HKD | 100.0% |
2021 Q2 | 45.18 Million HKD | 100.0% |
2021 Q3 | 18.21 Million HKD | -59.68% |
2020 Q2 | 22.8 Million HKD | 100.0% |
2020 Q4 | -9.42 Million HKD | -100.0% |
2020 FY | 22.31 Million HKD | -78.61% |
2020 Q1 | 11.4 Million HKD | -76.34% |
2020 Q3 | -4.71 Million HKD | -120.67% |
2019 Q2 | 53.67 Million HKD | 100.0% |
2019 Q1 | 26.83 Million HKD | -52.15% |
2019 FY | 104.31 Million HKD | -12.86% |
2019 Q4 | 48.19 Million HKD | 100.0% |
2019 Q3 | 24.09 Million HKD | -55.1% |
2018 FY | 119.71 Million HKD | -2.8% |
2018 Q4 | 56.08 Million HKD | 100.0% |
2018 Q3 | 28.04 Million HKD | -7.5% |
2018 Q2 | 30.31 Million HKD | 0.0% |
2018 Q1 | 30.31 Million HKD | 5.89% |
2017 Q1 | 25.77 Million HKD | -15.05% |
2017 FY | 123.16 Million HKD | 121.08% |
2017 Q4 | 28.63 Million HKD | 0.0% |
2017 Q3 | 28.63 Million HKD | 11.1% |
2017 Q2 | 25.77 Million HKD | 0.0% |
2016 FY | 55.7 Million HKD | -33.57% |
2016 Q1 | 25.14 Million HKD | 83.58% |
2016 Q2 | 25.14 Million HKD | 0.0% |
2016 Q4 | 30.33 Million HKD | 0.0% |
2016 Q3 | 30.33 Million HKD | 20.65% |
2015 Q4 | 13.69 Million HKD | -34.67% |
2015 Q3 | 20.96 Million HKD | 0.0% |
2015 Q2 | 20.96 Million HKD | 0.0% |
2015 Q1 | 20.96 Million HKD | 0.0% |
2015 FY | 83.86 Million HKD | 3.27% |
2014 FY | 81.2 Million HKD | 0.0% |
2014 Q4 | 20.96 Million HKD | -0.25% |
2014 Q3 | 21.02 Million HKD | 0.0% |
2014 Q2 | 21.02 Million HKD | 0.0% |
2014 Q1 | 21.02 Million HKD | 0.0% |
2013 Q4 | 21.02 Million HKD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | -3.73 Million HKD | 2268.593% |
Innovative Pharmaceutical Biotech Limited | -13.43 Million HKD | 703.409% |
China Overseas Nuoxin International Holdings Limited | -2.63 Million HKD | 3175.19% |
Prosperous Future Holdings Limited | -30.27 Million HKD | 367.781% |
Huasheng International Holding Limited | 994 Thousand HKD | -8055.131% |
Fourace Industries Group Holdings Limited | 39.7 Million HKD | -104.14% |
EC Healthcare | 186.03 Million HKD | 56.425% |
Ming Fai International Holdings Limited | 144.06 Million HKD | 43.732% |
Blue Moon Group Holdings Limited | 130.43 Million HKD | 37.853% |
SuperRobotics Holdings Limited | -7.88 Million HKD | 1128.706% |
Takbo Group Holdings Limited | 9.68 Million HKD | -736.812% |
Hyfusin Group Holdings Limited | 138.63 Million HKD | 41.527% |